Brokerage has given buy rating on these 5 stocks, can get strong returns (Image/AI)
Amidst the recent turmoil in the stock market, big brokerage houses have opened new avenues for investors. Leading institutions like Citi, Elara and Goldman Sachs have given their buy ratings on 5 stocks of energy finance, cement and pharma sectors. The third quarter results showed that the company has maintained its margin and volume growth despite the difficult circumstances. So let us analyze from this article those stocks which can give better returns in the coming time.
Keep an eye on these 5 stocks! (Stocks To Buy)
| Stock Name | Brokerage Firm | rating | Target Price (Rs) / Expected Return % |
| Mahanagar Gas | Citi | BUY | 1,610 – (36%) |
| India Shelter Finance | Citi | BUY | 1,120 – (45%) |
| Star Cement | ELARA | BUY | 302 – (39%) |
| Neuland Labs | goldman sachs | BUY | 17,325 – (28%) |
| Jyothy Labs | elara | BUY | 320 – (29%) |
Mahanagar Gas (MGL): Margin strength
Read full article
Citi has set a target price of ₹ 1,610 while advising investment on the shares of Mahanagar Gas (MGL). In the results of the third quarter of FY 2026, the company has recorded EBITDA 14% higher than expected. The most important thing was that despite rising gas prices and currency fluctuations, the company did not let its margins weaken.
India Shelter Finance: Profitability and strength
Citi has kept a target price of ₹ 1,120 on this company of housing finance sector. Although there has been a slight softening in the company’s asset quality, its spreads have improved, which is supporting profits. Experts have advised to buy it.
star cement
Elara Capital has set a target price of ₹302 on Star Cement. The company has recorded the best margins in the sector (₹1,562 per tonne) for the fourth consecutive quarter. The company’s EBITDA grew by 94% on a year-on-year basis due to better volume growth and lower fuel costs.
Newland Labs: A buying opportunity in the fall
Goldman Sachs has set a target price of ₹17,325 for Newland Labs. Although the brokerage has slightly cut the target, it has maintained ‘buy’ rating. Quarterly results were a bit weak due to shipment delays, but the company’s CMS segment is growing with strong growth of 74%.
Jyoti Labs: Emphasis on volume growth
Elara has set a target price of ₹320 on Jyoti Labs shares. The company has registered a volume growth of 7.2%. The future of the company looks positive due to its strong hold in segments like fabric care and personal care.
Disclaimer: This article is for informational purposes only and should not be construed as investment advice in any way. ET NOW Swadesh recommends its readers and viewers to consult their financial advisors before taking any money-related decisions.
related news
end of article
